Download | < Back |
16 May 2015 | |
In compliance with the requirements of the SEBI (Prohibition of Insider Trading) Regulations, 2015 ("the Regulations"), Sun Pharmaceutical Industries Ltd has informed BSE as follows:<BR><BR>1. Pursuant to the requirements of regulation 8(2) of the Regulations, the Company have formulated & published on its website the "Code of Practices & Procedures for Fair Disclosure of Unpublished Price Sensitive Information".<BR><BR>2. Pursuant to the requirements of regulation 9(1) of the Regulations, the Company has formulated a Code of Internal Procedures and Code of Conduct for Prevention of Insider Trading. | |
View all announcements for SUN PHARMACEUTICAL INDUSTRIES LTD. | Source: BSE India |